Mubadala Bio, the national specialized pharmaceutical manufacturing company in the UAE aimed at enhancing the pharmaceutical industry ecosystem in the country, announced the completion of the full acquisition of 'Al Ittihad Pharmaceuticals' and 'Global Medical Supply Chain' from Global One Healthcare Holding, a subsidiary of Yas Holding Group. This follows the initial 80% acquisition completed at the end of 2024. This acquisition represents a significant step in Mubadala Bio's journey to build a comprehensive pharmaceutical manufacturing ecosystem in the United Arab Emirates. Dr. Buhith Al-Kutairi, UAE Investment Sector CEO at Mubadala and Chairman of the Board of Directors of Mubadala Bio, said: 'This strategic step supports the direction...'
Mubadala Bio Completes Full Acquisition of Two Pharmaceutical Companies in UAE
Mubadala Bio, a UAE-based pharmaceutical leader, announced the full acquisition of Al Ittihad Pharmaceuticals and Global Medical Supply Chain. This strategic move strengthens the nation's pharmaceutical industry and is a key step in building a complete ecosystem.